Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy

AIMS/INTRODUCTION: Small dense low‐density lipoprotein (sdLDL) is a more potent atherogenic lipoprotein than LDL. As sdLDL‐cholesterol (C) levels are determined by triglyceride and LDL‐C levels, pemafibrate and statins can reduce sdLDL‐C levels. However, it remains unclear whether adding pemafibrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirano, Tsutomu, Hayashi, Toshiyuki, Sugita, Hiroe, Tamasawa, Atsuko, Goto, Satoshi, Tomoyasu, Masako, Yamamoto, Takeshi, Ohara, Makoto, Terasaki, Michishige, Kushima, Hideki, Ito, Yasuki, Yamagishi, Sho‐ichi, Mori, Yusaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688129/
https://www.ncbi.nlm.nih.gov/pubmed/37647503
http://dx.doi.org/10.1111/jdi.14076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688129/
https://www.ncbi.nlm.nih.gov/pubmed/37647503
http://dx.doi.org/10.1111/jdi.14076

Ejemplares similares